Does addition of 1-octanol as a phase modifier provide radical scavenging radioprotection for N,N,N',N'-tetraoctyldiglycolamide (TODGA)?

To mitigate third phase formation in next generation used nuclear fuel reprocessing technologies, the addition of 1-octanol has been trialed. However, contradictory reports on the radiolytic effect of 1-octanol incorporation on separation ligand degradation need to be resolved. Here, 50 mM N,N,N',N'-tetraoctyldiglycolamide (TODGA) dissolved in n-dodecane was gamma irradiated in the presence and absence of 1-octanol (2.5-10 vol%) and a 3.0 M HNO aqueous phase. Radiation-induced TODGA degradation exhibited pseudo-first-order decay kinetics as a function of absorbed gamma dose for all investigated solution and solvent system formulations. The addition of 1-octanol afforded diametrically different effects on the rate of TODGA degradation depending on solvent system formulation. For organic-only irradiations, 1-octanol promoted TODGA degradation (d = 0.0057 kGy for zero 1-octanol present vs.∼0.0073 kGy for 7.5-10 vol%) attributed to a favourable hydrogen atom abstraction reaction free energy (-0.31 eV) and the ability of 1-octanol to access a higher yield of n-dodecane radical cation (RH˙) at sub-nanosecond timescales. This was rationalized by determination of the rate coefficient (k) for the reaction of 1-octanol with RH˙, k = (1.23 ± 0.07) × 10 M s. In contrast, irradiation in the presence of 1-octanol and a 3.0 M HNO aqueous phase afforded significant radioprotection (d = 0.0054 kGy for zero 1-octanol present vs.≤ 0.0044 kGy for >2.5 vol%) that increases with 1-octanol concentration, relative to the single phase, organic-only solutions. This effect was attributed to the extraction of sufficiently high concentrations of HNO and HO into the organic phase by TODGA and 1-octanol as adducts which interfere with the hydrogen atom abstraction process between the 1-octanol radical and TODGA. Our findings suggest that the addition of 1-octanol as a phase modifier will enhance the radiation robustness of TODGA-based separation technologies under envisioned solvent system conditions in the presence of aqueous HNO.